This application relates to methods and compositions for treating rheumatoid arthritis by administering a combination therapy comprising methotrexate and an antibody to alpha-4 integrin or an immunologically active antigen binding fragment in therapeutically effective amounts. The application also relates generally to methods and compositions for treating rheumatoid arthritis by administering a combination therapy comprising methotrexate and small molecule alpha-4 integrin antagonist that inhibits the alpha-4 integrin (α4 integrin) interaction with VCAM-1. The invention further relates to methods of preparing the compounds and methods of using the compounds and compositions.
本申请涉及通过以治疗有效剂量给予
甲氨蝶呤和α-4整合素
抗体或免疫活性抗原结合片段的联合治疗方法和组合物,治疗类风湿性关节炎。该申请还涉及通过以治疗有效剂量给予
甲氨蝶呤和小分子α-4整合素拮抗剂的联合治疗方法和组合物,该拮抗剂抑制α-4整合素(α4整合素)与VCAM-1的相互作用,通常涉及制备化合物的方法和使用化合物和组合物的方法。